3D0A.F Telo Genomics Corp

Healthcare Biotechnology Frankfurt Exchange
0.0235 EUR
Close of Nov 12, 2026
0.0005 0.0360
Market cap
EUR 2.36M
P/E
-
P/B
1.98x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Mar 2026.

Is 3D0A.F undervalued?

Graham number

The Graham number of Telo Genomics Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Telo Genomics Corp fundamental analysis

No fundamental analysis for Telo Genomics Corp yet.

Telo Genomics Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Telo Genomics Corp

Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada. The company's TeloView platform measures the 3D structure and spatial organization of telomeres to inform on genetic and molecular characteristics that are predictive of genomic instability, identify specific disease mechanisms, predict disease ris…

Full company profile